CHINA PHARMA HOLDINGS, INC. Lessee, Operating Lease, Liability, to be Paid
CHINA PHARMA HOLDINGS, INC. (CPHI) had Lessee, Operating Lease, Liability, to be Paid of $153.04 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-08-14
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid $153.04K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid $169.47K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $190.36K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid $207.13K.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2026-06-30 | $153.04K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $169.47K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $190.36K 10-K · filed 2026-04-01 |
| 2025-09-30 | $207.13K 10-Q · filed 2025-11-12 |
| 2025-03-31 | $19.89K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $39.73K 10-K · filed 2025-03-31 |
| 2024-09-30 | $61.13K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $80.15K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $120.97K 10-K · filed 2024-04-01 |
| 2023-09-30 | $139.22K 10-Q · filed 2023-11-13 |
| 2020-12-31 | $52.81K 10-K · filed 2021-03-26 |
| 2020-09-30 | $75.18K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $95.97K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $119.52K 10-Q · filed 2020-05-14 |
| 2019-09-30 | $167.06K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $196.23K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $225.96K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |